Profusa (NVACW) Interest & Investment Income (2022 - 2025)
Profusa (NVACW) reported Interest & Investment Income of $15159.0 for Q2 2025, down 86.03% on a YoY basis from $108520.0 in Q2 2024, and down 81.03% quarter-over-quarter from $79925.0 in Q1 2025.
Profusa (NVACW) Interest & Investment Income (2022 - 2025) Analysis & Trends
Profusa has reported Interest & Investment Income for 4 years, with the latest figure at $15159.0 in Q2 2025.
- For the quarter ending Q2 2025, Interest & Investment Income fell 86.03% year-over-year to $15159.0; the trailing twelve-month figure through Jun 2025 stood at -$13436.0 (down 102.64% YoY), and the FY2024 full-year result was $116664.0, down 94.81% from the prior year.
- Interest & Investment Income for Q2 2025 stood at $15159.0, down from $79925.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.8 million in Q1 2023, with the low at -$217270.0 in Q4 2024.
- Historically, Interest & Investment Income has averaged $360194.2 across 4 years, with a median of $119605.0 in 2023.
- Annual changes were most pronounced in 2023 — Interest & Investment Income surged 2438.39% — and 2024, when it slumped 249.4%.
- Profusa's Interest & Investment Income stood at $1.2 million in 2022, then plunged by 87.96% to $145427.0 in 2023, then tumbled by 249.4% to -$217270.0 in 2024, then surged by 106.98% to $15159.0 in 2025.
- The last three Interest & Investment Income figures came in at $15159.0 (Q2 2025), $79925.0 (Q1 2025), and -$217270.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 40.98 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Profusa | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 15,159.00 |
| Mar 31, 2025 | 79,925.00 |
| Dec 31, 2024 | -217,270.00 |
| Sep 30, 2024 | 108,750.00 |
| Jun 30, 2024 | 108,520.00 |
| Mar 31, 2024 | 116,664.00 |
| Dec 31, 2023 | 145,427.00 |
| Sep 30, 2023 | 138,725.00 |
| Jun 30, 2023 | 122,546.00 |
| Mar 31, 2023 | 1.85 Mn |
| Dec 31, 2022 | 1.21 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 161,816.00 |
| Mar 31, 2022 | 72,684.00 |